[Walnut Creek, CA] Alzheimer's Disease Neuroimaging Initiative study

Enter your info and the study team will contact you soon!
Your data is securely stored and only shared with the research team
Data is not saved in preview.
"Help to understand how Alzheimer's Disease develops!"
Age:
55 Years to 90 Years
Gender:
Any
Healthy Volunteers:
Yes
Keywords:
Mild Cognitive Impairment (MCI), Alzheimer's Disease (AD)
Type:
Observational, Imaging Study
Target:
2000 Participants
Investigator:
Description
The overall goal of this study is to discover and study the clinical, cognitive, imaging, genetic and biochemical biomarkers as the Alzheimer's disease (AD) evolves from normal aging through very mild symptoms, to mild cognitive impairment (MCI), to dementia.

This is a large public/private collaboration between academia and industry to study biomarkers of AD. Approximately 1070 - 2000 participants will be enrolled in the United States and Canada. The study has many important scientific implications: understanding biology of AD, identify various markers, and help develop the most effective clinical trials.

This study does not involve any treatments. Participants will need to be 55 - 90 years, otherwise healthy with no neurologic symptoms, such as diagnosed Alzheimer's disease.
This study requires
Participants will undergo multiple clinical and cognitive assessments over time. These may include computerized cognitive tests, blood biomarker and genetic tests, imaging scans and cerebral spinal fluid (CSF) collection for up to 5 years.
Who can participate?
Cognitively normal (CN), mild cognitive impairment (MCI), and mild AD dementia participants. We invite individuals with or without subjective memory complaints. A complete list of criteria may be discussed with the study team.
Benefits and risks of participating
We hope the knowledge gained will be beneficial to society in improving our understanding of risk for cognitive decline in older individuals. The data from this research study will be used in the development of future research studies that will focus on the treatment of AD at an early stage.
Compensation
Cognitively Normal (CN) participants will receive total compensation of up to $1325.

Mild Cognitive Impairment (MCI) participants will receive total compensation of up to $1525.

Alzheimer's Disease (AD) participants will receive total compensation of up to $1575.

Participants will also receive a $50.00
gift card annually beginning at the 1st year anniversary of participating in this study.
Resources
PDF Docs
Informed Consent Document
Schedule
Study duration and period
This is a study that takes yearly visits and on line computer test. Overall participation last between 3-5 years
Location
UC Davis Alzheimer's Disease Center
100 North Wiget Lane
Suite 150
Walnut Creek, CA 94598
Contact
Hongzheng Zhang

Have any questions or want to learn more? Leave your contact details below and the research team will reach out to you.


Sending

Send SMS with Study Info:

SMS Sent!

Share Study Info via Email:


E-mail Preview